| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = $0 ) |
| | 2027 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK127916 | BRinging the Diabetes Prevention Program to GEriatric Populations (BRIDGE) | 000 | 5 | NIH | 10/8/2026 | $0 |
| | 2027 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21MH136644 | In vivo assessment of the mitochondrial complex I in subjects with schizophrenia | 000 | 2 | NIH | 10/9/2026 | $0 |
| | 2027 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AI182549 | Molecular control of tolerogenic dendritic cell function | 000 | 2 | NIH | 10/8/2026 | $0 |
| | 2027 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MD018520 | Partners IN CONTROL: Using Remote MonitorINg teChnology with cOmmuNity healTh woRkers to support hypertensiOn management patients at Federally QuaLified Health Centers | 000 | 4 | NIH | 10/8/2026 | $0 |
| | 2027 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | 90IFRE0116 | ACCESSIBLE - Advanced Communication and Care in Safety-net Systems | 01 | 2 | ACL | 10/8/2026 | $0 |
| | 2027 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K99DC021727 | Neuroplasticity and early cochlear implant use | 000 | 2 | NIH | 10/9/2026 | $0 |
| | 2027 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA282756 | Exploiting cell fate transition to overcome radiation resistance in glioblastoma | 000 | 3 | NIH | 10/8/2026 | $0 |
| | 2027 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | 90IFRE0116 | ACCESSIBLE - Advanced Communication and Care in Safety-net Systems | 01 | 2 | ACL | 10/8/2026 | $0 |
| | 2027 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | 90IFRE0116 | ACCESSIBLE - Advanced Communication and Care in Safety-net Systems | 01 | 2 | ACL | 10/8/2026 | $0 |
|
| Issue Date FY: 2026 ( Subtotal = $462,593,264 ) (Continued on the next page) |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32AI197563 | Blocking pathogenic anti-donor antibody responses | 000 | 1 | NIH | 3/30/2026 | $75,520 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HG014543 | Ethical Considerations and Barriers to Generalizable Evidence and Data Sharing for Individualized Genomic Therapies | 000 | 1 | NIH | 8/25/2026 | $2,722,562 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL178822 | Regulation of atherosclerotic cardiovascular disease by long non-coding RNA IRF1-AS1 | 000 | 1 | NIH | 8/19/2026 | $763,960 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32EY038561 | Mechanisms of global visual stability across eye movements | 000 | 1 | NIH | 8/25/2026 | $79,780 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK144370 | Identifying modifiable process delays in deceased donor kidney allocation through process mining | 000 | 1 | NIH | 8/20/2026 | $872,273 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | P01HL187163 | Macrophages, Cell-Intrinsic and Cell-Cell Communications, Ischemic Injury, Diabetes and the RAGE/DIAPH1 Signaling Axis | 001 | 1 | NIH | 8/26/2026 | $0 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01ES037626 | Nickel exposure disrupts Sp1/ZEB1-dependent transcriptional regulation | 000 | 1 | NIH | 6/23/2026 | $3,234,310 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | P01HL187163 | Macrophages, Cell-Intrinsic and Cell-Cell Communications, Ischemic Injury, Diabetes and the RAGE/DIAPH1 Signaling Axis | 000 | 1 | NIH | 8/25/2026 | $2,567,368 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K99EY037847 | Investigating the mechanism of corneal lens development | 001 | 2 | NIH | 8/25/2026 | $142,749 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21NS153418 | Characterization of ARIA by neuroimaging, proteomics, and neuropathology in a Squirrel monkey model of sporadic CAA | 000 | 1 | NIH | 9/1/2026 | $466,125 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R33MH131041 | Promoting Mental Health of Teachers and Caregivers using a Personalized mHealth Toolkit in Uganda | 003 | 4 | NIH | 9/3/2026 | $97,132 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL181640 | Mechanisms of Sex-specific responses to obstructive sleep apnea Therapies (MoST) | 000 | 1 | NIH | 8/31/2026 | $795,421 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R33MH131041 | Promoting Mental Health of Teachers and Caregivers using a Personalized mHealth Toolkit in Uganda | 002 | 4 | NIH | 8/24/2026 | $186,555 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DA063711 | NY MOVES: Evaluating the Impact of New York’s Methadone Outreach VEhicleS | 001 | 2 | NIH | 5/25/2026 | $775,500 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA302397 | The Cellular Properties and Pathogenesis of Double-Null Prostate Cancer | 000 | 1 | NIH | 9/1/2026 | $580,131 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DC023790 | Cortical mechanisms of normal and disordered human speech | 000 | 1 | NIH | 6/26/2026 | $685,327 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23HD120657 | Drivers and Consequences of Movement Anxiety after Stroke | 000 | 1 | NIH | 8/31/2026 | $179,495 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG099916 | Post-Kidney Transplant Dementia and Alzheimer's Disease Prediction Leveraging the Pre-Transplant Evaluation Data | 000 | 1 | NIH | 9/1/2026 | $1,423,551 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK149150 | Effect of State-Wide Centralized Patient Coaching about Live Donor Kidney Transplantation | 000 | 1 | NIH | 9/2/2026 | $877,742 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AR087136 | Defining Flares in VEXAS Syndrome | 000 | 1 | NIH | 9/11/2026 | $446,173 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AA033825 | RCT of a transdiagnostic intervention to reduce alcohol-related and other preventable mortality for people with HIV and other chronic conditions | 000 | 1 | NIH | 9/18/2026 | $2,299,623 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K99NR022359 | Leveraging Nurses to Improve Care for Postural Orthostatic Tachycardia Syndrome | 000 | 1 | NIH | 9/18/2026 | $133,547 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UG3CA309249 | The Non Invasive Post Polypoectomy Surveillance Study (NIPPSS) | 000 | 1 | NIH | 9/3/2026 | $671,426 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK146063 | Identifying Neural and Computational Underpinnings of Self-Control Costs in Obesity and Loss-of-Control Eating | 000 | 1 | NIH | 9/3/2026 | $861,091 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | T3555551 | Primary Care Training and Enhancement -- Residency Training in Street Medicine | 01 | 1 | HRSA | 7/27/2026 | $0 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | T3555551 | Primary Care Training and Enhancement -- Residency Training in Street Medicine | 00 | 1 | HRSA | 5/14/2026 | $499,978 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | H79SM091321 | The Center for Safe and Effective Trauma Treatment (CSETT) | 000 | 1 | SAMHSA | 9/2/2026 | $599,600 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R61HL186125 | Combination Therapy with High-Flow Nasal Cannula and Continuous Negative Extrathoracic Pressure for Acute Hypoxemic Respiratory Failure | 000 | 1 | NIH | 9/14/2026 | $763,434 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01CA294194 | Cancer Informatics Data Provenance with the Executive | 000 | 1 | NIH | 9/14/2026 | $422,053 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AR088257 | Decoding Nutritional Control of Bone Marrow Fat and Skeletal Stem Cell Dynamics | 000 | 1 | NIH | 9/14/2026 | $396,206 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31DK146642 | Examining Real-World Uptake and Effectiveness of GLP-1 RA in an Urban Population with Type-2 Diabetes | 000 | 1 | NIH | 9/17/2026 | $36,947 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AR087005 | MRI as a Predictive Biomarker for Hip Arthroplasty Failure | 000 | 1 | NIH | 9/7/2026 | $661,706 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HD123105 | Child Health Impacts of Injury in Pregnancy (CHIIP) | 000 | 1 | NIH | 9/17/2026 | $727,664 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DC024134 | Precision Glucocorticoid Therapy for Vocal Fold Disorders | 000 | 1 | NIH | 9/17/2026 | $706,136 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL188015 | Testing various antiplatelet strategies in psoriasis to improve vascular health | 000 | 1 | NIH | 9/9/2026 | $845,590 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R35GM163773 | Mechanisms of gene activating and silencing chromatin complexes | 000 | 1 | NIH | 9/17/2026 | $313,896 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DE035954 | Impacts of fluoride exposure on child neurodevelopment: a mechanistic study | 000 | 1 | NIH | 9/7/2026 | $691,724 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA312541 | Psilocybin-assisted Psychotherapy to Treat Fear of Cancer Recurrence in Early- Stage Breast Cancer | 000 | 1 | NIH | 9/8/2026 | $693,638 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30HL184849 | Tissue-Specific Gene Editing via Programmable Sendai -based Vectors (PSVs) | 000 | 1 | NIH | 9/17/2026 | $55,114 |
|
